These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37678877)

  • 21. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.
    Sakao S; Voelkel NF; Tatsumi K
    Eur Respir Rev; 2014 Sep; 23(133):350-5. PubMed ID: 25176971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-4 and tumour necrosis factor-alpha inhibit transforming growth factor-beta production in a human bronchial epithelial cell line: possible relevance to inflammatory mechanisms in chronic obstructive pulmonary disease.
    Hodge S; Hodge G; Holmes M; Flower R; Scicchitano R
    Respirology; 2001 Sep; 6(3):205-11. PubMed ID: 11555378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New pathophysiological concepts in pulmonary hypertension in COPD].
    Firă-Mladinescu O; Tudorache V; Mihăicuţă S; Cristescu A
    Pneumologia; 2003; 52(3-4):188-92. PubMed ID: 18210732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical perspective of hypoxia-mediated pulmonary hypertension.
    Preston IR
    Antioxid Redox Signal; 2007 Jun; 9(6):711-21. PubMed ID: 17511586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development.
    Yang Q; Underwood MJ; Hsin MK; Liu XC; He GW
    Curr Drug Metab; 2008 Sep; 9(7):661-7. PubMed ID: 18781916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary hypertension and cor pulmonale in COPD].
    Kuwahira I; Iwamoto T
    Nihon Rinsho; 2003 Dec; 61(12):2138-43. PubMed ID: 14674323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.
    Adegunsoye A; Balachandran J
    Mediators Inflamm; 2015; 2015():510105. PubMed ID: 25944985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD.
    Osei ET; Brandsma CA; Timens W; Heijink IH; Hackett TL
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31727692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Jiang YW; Pang L; Fang QH; Ma YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.
    Humbert M; Monti G; Brenot F; Sitbon O; Portier A; Grangeot-Keros L; Duroux P; Galanaud P; Simonneau G; Emilie D
    Am J Respir Crit Care Med; 1995 May; 151(5):1628-31. PubMed ID: 7735624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.
    Damera G; Pham TH; Zhang J; Ward CK; Newbold P; Ranade K; Sethi S
    Lung; 2016 Jun; 194(3):363-9. PubMed ID: 27083436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aqp-1 Gene Knockout Attenuates Hypoxic Pulmonary Hypertension of Mice.
    Liu M; Liu Q; Pei Y; Gong M; Cui X; Pan J; Zhang Y; Liu Y; Liu Y; Yuan X; Zhou H; Chen Y; Sun J; Wang L; Zhang X; Wang R; Li S; Cheng J; Ding Y; Ma T; Yuan Y
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):48-62. PubMed ID: 30580569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.
    Sydykov A; Mamazhakypov A; Maripov A; Kosanovic D; Weissmann N; Ghofrani HA; Sarybaev AS; Schermuly RT
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33578749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.
    Chen BB; Li ZH; Gao S
    Medicine (Baltimore); 2018 Feb; 97(7):e9820. PubMed ID: 29443743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients.
    Casadevall C; Coronell C; Ramírez-Sarmiento AL; Martínez-Llorens J; Barreiro E; Orozco-Levi M; Gea J
    Eur Respir J; 2007 Oct; 30(4):701-7. PubMed ID: 17626109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights by Peruvian scientists into the pathogenesis of human chronic hypoxic pulmonary hypertension.
    Reeves JT; Grover RF
    J Appl Physiol (1985); 2005 Jan; 98(1):384-9. PubMed ID: 15591308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].
    Wu XC; Liu Y; Bai ZP
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3055-3065. PubMed ID: 37381964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways.
    Vitenberga Z; Pilmane M; Babjoniševa A
    Pathol Res Pract; 2019 Jan; 215(1):97-105. PubMed ID: 30392917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent short-duration reoxygenation protects against simulated high altitude-induced pulmonary hypertension in rats.
    Lyu Q; Bai Y; Cheng J; Liu H; Li S; Yang J; Wang Z; Ma Y; Jiang M; Dong D; Yan Y; Shi Q; Ren X; Ma J
    FASEB J; 2021 Feb; 35(2):e21212. PubMed ID: 33230951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?
    Blanco I; Torres-Castro R; Barberà JA
    Curr Opin Pulm Med; 2024 Sep; 30(5):437-443. PubMed ID: 38958570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.